î
îŒ
ãã°ã€ã³
î
Neurosense Therapeutics Ltd
NRSN0.770USD
0.0000.00%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
8.74Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Neurosense Therapeutics Ltd äŒæ¥å
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãNRSN
äŒç€ŸåNeurosense Therapeutics Ltd
äžå Žæ¥Dec 09, 2021
æé«çµå¶è²¬ä»»è
ãCEOãBen-Noon (Alon)
åŸæ¥å¡æ°15
蚌åžçš®é¡Ordinary Share
決ç®ææ«Dec 09
æ¬ç€Ÿæåšå°11 Hamenofim St.
éœåžHERZLIYA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·4672562
é»è©±çªå·97297996183
ãŠã§ããµã€ãhttps://www.neurosense-tx.com/
äŒæ¥ã³ãŒãNRSN
äžå Žæ¥Dec 09, 2021
æé«çµå¶è²¬ä»»è
ãCEOãBen-Noon (Alon)
Neurosense Therapeutics Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+2.95%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.35%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+35.16%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+2.95%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.35%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+35.16%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Sun, Feb 15
æŽæ°æå»: Sun, Feb 15
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Ben-Noon (Alon)
9.51%
Rimon Gold Assets Ltd
6.90%
Eisenberg (Or)
1.44%
Tracik (Ferenc)
0.57%
Yorkville Advisors Global, LP.
0.30%
ä»ã®
81.29%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Ben-Noon (Alon)
9.51%
Rimon Gold Assets Ltd
6.90%
Eisenberg (Or)
1.44%
Tracik (Ferenc)
0.57%
Yorkville Advisors Global, LP.
0.30%
ä»ã®
81.29%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Individual Investor
12.26%
Corporation
6.90%
Investment Advisor/Hedge Fund
0.44%
Investment Advisor
0.35%
Hedge Fund
0.15%
Family Office
0.05%
Bank and Trust
0.04%
ä»ã®
79.81%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Thu, Jan 1
æŽæ°æå»: Thu, Jan 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
30
293.14K
0.99%
-2.10M
2025Q3
29
437.13K
1.75%
-1.60M
2025Q2
37
7.64M
31.03%
+143.76K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Ben-Noon (Alon)
3.18M
10.69%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
7.76%
+2.30M
--
Dec 02, 2024
Eisenberg (Or)
480.92K
1.62%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.64%
+66.67K
+54.22%
Apr 07, 2025
Russek-Blum (Niva)
75.43K
0.25%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.22%
--
--
Apr 07, 2025
Two Sigma Investments, LP
21.09K
0.07%
+21.09K
--
Sep 30, 2025
Meitav Investment House Ltd
40.00K
0.13%
--
--
Sep 30, 2025
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
